eonatal Jaundice Treatment
Phase 3
Recruiting
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT20190105042241N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Term neonatal
Neonatal weight between 2500- 4000 grams
2-7 days old neonatal
Total serum bilirubin level 13-25 mg/dl
Direct bilirubin level less than 2 mg/dL or less than 15% from total serum bilirubin
Exclusion Criteria
Infants with sepsis disease
meningitis
congenital anomalies
dehydration
hemolytic disease
Conjugate Hyperbilirubinemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total serum bilirubin. Timepoint: Before starting treatment and 12 and 24 hours after starting treatment. Method of measurement: Standard protocol (Using diazo solutions and photometric method).;Serum conjugated bilirubin. Timepoint: Before starting treatment and 12 and 24 hours after starting treatment. Method of measurement: Standard protocol (photometric method).
- Secondary Outcome Measures
Name Time Method ength of hospitalization. Timepoint: End of study. Method of measurement: Based on hours.